Christopher van Dyck MD

Professor of Psychiatry, Neurology, and Neurobiology; Director, Alzheimer's Disease Research Unit

Biographical Info

Christopher H. van Dyck, MD, is Professor of Psychiatry, Neurology, and Neurobiology, and Director of the Alzheimer's Disease Research Unit at Yale. His research interests include therapeutic, neuroimaging and genetic studies of Alzheimer's disease (AD) and healthy cognitive aging. Dr. van Dyck is very active in AD therapeutic research. Since 1992 he has participated in 70+ multicenter clinical trials for AD and MCI and has authored several of the trial publications. He serves on the Steering Committees of the NIA Alzheimer's Disease Cooperative Study (ADCS) and Alzheimer's Disease Neuroimaging Initiative (ADNI). Dr. van Dyck’s other significant scholarly contributions include dopamine transporter imaging in healthy aging and the apolipoprotein E e4 Phenotype of AD. In 2005 he received the "Compassion and Cure" Award from the Alzheimer's Association.


Education & Training

B.A.
Yale University (1978)
M.D.
Northwestern University (1984)
Resident
Yale-New Haven Hospital, Psychiatry
Fellow
Yale University School of Medicine, Geriatric Psychiatry
Board Certification
Geriatric Psychiatry, Board Certified  (1994)
Board Certification
Psychiatry, Board Certified  (1991)

Honors & Recognition

  • Best Doctors in New York (Top 2%), as Featured in New York Magazine
    Castle Connolly (2005-2009)
  • “Compassion and Cure” Award
    Alzheimer’s Association (2005)
  • Junior Investigator Award
    American Association for Geriatric Psychiatry (1996)

Edit Profile